DIAGNOS Inc. (DGNOF)
USD 0.23
(0.0%)
USD 0.23
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 663.78 Thousand CAD | -19.35% |
| 2023 | 823.03 Thousand CAD | -57.8% |
| 2022 | 1.95 Million CAD | -19.87% |
| 2021 | 2.43 Million CAD | 101.63% |
| 2020 | 1.2 Million CAD | 0.0% |
| 2019 | 1.2 Million CAD | -20.8% |
| 2018 | 1.52 Million CAD | 16.42% |
| 2017 | 1.3 Million CAD | 3.04% |
| 2016 | 1.27 Million CAD | 8.39% |
| 2015 | 1.17 Million CAD | -25.71% |
| 2014 | 1.57 Million CAD | -28.98% |
| 2013 | 2.22 Million CAD | -16.21% |
| 2012 | 2.65 Million CAD | 75.17% |
| 2011 | 1.51 Million CAD | -33.42% |
| 2010 | 2.27 Million CAD | -14.61% |
| 2009 | 2.66 Million CAD | -45.34% |
| 2008 | 4.87 Million CAD | 204.16% |
| 2007 | 1.6 Million CAD | 66.1% |
| 2006 | 964.27 Thousand CAD | 155.93% |
| 2005 | 376.77 Thousand CAD | -47.08% |
| 2004 | 711.9 Thousand CAD | 183.79% |
| 2003 | 250.85 Thousand CAD | -27.68% |
| 2002 | 346.87 Thousand CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q4 | 663.78 Thousand CAD | -20.8% |
| 2024 FY | 663.78 Thousand CAD | -19.35% |
| 2024 Q1 | 907 Thousand CAD | 10.2% |
| 2024 Q2 | 805.94 Thousand CAD | -11.14% |
| 2024 Q3 | 838.09 Thousand CAD | 3.99% |
| 2023 Q2 | 805.94 Thousand CAD | -11.14% |
| 2023 FY | 823.03 Thousand CAD | -57.8% |
| 2023 Q4 | 823.03 Thousand CAD | -36.49% |
| 2023 Q1 | 907 Thousand CAD | -41.16% |
| 2023 Q3 | 1.29 Million CAD | 60.79% |
| 2022 Q4 | 1.54 Million CAD | 41.99% |
| 2022 Q3 | 1.08 Million CAD | -30.67% |
| 2022 Q1 | 1.87 Million CAD | -3.62% |
| 2022 Q2 | 1.56 Million CAD | -16.7% |
| 2022 FY | 1.95 Million CAD | -19.87% |
| 2021 Q1 | 1.95 Million CAD | -19.88% |
| 2021 FY | 2.43 Million CAD | 101.63% |
| 2021 Q2 | 1.94 Million CAD | -0.07% |
| 2021 Q3 | 2.02 Million CAD | 4.09% |
| 2021 Q4 | 1.95 Million CAD | -3.85% |
| 2020 FY | 1.2 Million CAD | 0.0% |
| 2020 Q3 | 661.84 Thousand CAD | -16.43% |
| 2020 Q4 | 2.43 Million CAD | 267.75% |
| 2020 Q2 | 791.93 Thousand CAD | 39.71% |
| 2020 Q1 | 566.84 Thousand CAD | -53.04% |
| 2019 Q1 | 858.14 Thousand CAD | -43.7% |
| 2019 FY | 1.2 Million CAD | -20.8% |
| 2019 Q2 | 838.57 Thousand CAD | -2.28% |
| 2019 Q4 | 1.2 Million CAD | -34.9% |
| 2019 Q3 | 1.85 Million CAD | 121.14% |
| 2018 Q1 | 2.7 Million CAD | 106.98% |
| 2018 FY | 1.52 Million CAD | 16.42% |
| 2018 Q4 | 1.52 Million CAD | -49.74% |
| 2018 Q2 | 1.8 Million CAD | -33.43% |
| 2018 Q3 | 3.03 Million CAD | 68.1% |
| 2017 Q1 | 1.14 Million CAD | -9.58% |
| 2017 Q3 | 1.94 Million CAD | -0.6% |
| 2017 Q4 | 1.3 Million CAD | -32.85% |
| 2017 FY | 1.3 Million CAD | 3.04% |
| 2017 Q2 | 1.96 Million CAD | 70.72% |
| 2016 FY | 1.27 Million CAD | 8.39% |
| 2016 Q4 | 1.27 Million CAD | -7.37% |
| 2016 Q3 | 1.37 Million CAD | -30.32% |
| 2016 Q2 | 1.96 Million CAD | 114.39% |
| 2016 Q1 | 918.21 Thousand CAD | -21.67% |
| 2015 Q4 | 1.17 Million CAD | -27.54% |
| 2015 Q1 | 1.04 Million CAD | -33.74% |
| 2015 Q3 | 1.61 Million CAD | -30.67% |
| 2015 FY | 1.17 Million CAD | -25.71% |
| 2015 Q2 | 2.33 Million CAD | 123.18% |
| 2014 FY | 1.57 Million CAD | -28.98% |
| 2014 Q2 | 1.85 Million CAD | 1.31% |
| 2014 Q3 | 1.37 Million CAD | -25.84% |
| 2014 Q1 | 1.83 Million CAD | -17.49% |
| 2014 Q4 | 1.57 Million CAD | 14.57% |
| 2013 Q1 | 1.9 Million CAD | -28.26% |
| 2013 Q2 | 1.41 Million CAD | -25.78% |
| 2013 Q3 | 834.17 Thousand CAD | -40.92% |
| 2013 Q4 | 2.22 Million CAD | 166.34% |
| 2013 FY | 2.22 Million CAD | -16.21% |
| 2012 Q2 | 3.3 Million CAD | -12.67% |
| 2012 Q3 | 2.95 Million CAD | -10.55% |
| 2012 Q4 | 2.65 Million CAD | -10.38% |
| 2012 FY | 2.65 Million CAD | 75.17% |
| 2012 Q1 | 3.78 Million CAD | 150.2% |
| 2011 Q4 | 1.51 Million CAD | -12.73% |
| 2011 FY | 1.51 Million CAD | -33.42% |
| 2011 Q2 | 1.63 Million CAD | -16.9% |
| 2011 Q1 | 1.96 Million CAD | -13.39% |
| 2011 Q3 | 1.73 Million CAD | 5.99% |
| 2010 Q4 | 2.27 Million CAD | -13.03% |
| 2010 Q2 | 1.69 Million CAD | -23.53% |
| 2010 FY | 2.27 Million CAD | -14.61% |
| 2010 Q1 | 2.21 Million CAD | -16.81% |
| 2010 Q3 | 2.61 Million CAD | 54.34% |
| 2009 Q3 | 3.94 Million CAD | -13.56% |
| 2009 Q1 | 4.78 Million CAD | -1.82% |
| 2009 Q2 | 4.56 Million CAD | -4.48% |
| 2009 FY | 2.66 Million CAD | -45.34% |
| 2009 Q4 | 2.66 Million CAD | -32.58% |
| 2008 Q1 | 1.44 Million CAD | -10.09% |
| 2008 Q2 | 1.4 Million CAD | -2.64% |
| 2008 Q3 | 1.75 Million CAD | 24.91% |
| 2008 Q4 | 4.87 Million CAD | 178.18% |
| 2008 FY | 4.87 Million CAD | 204.16% |
| 2007 FY | 1.6 Million CAD | 66.1% |
| 2007 Q4 | 1.6 Million CAD | 2.26% |
| 2007 Q3 | 1.56 Million CAD | 69.34% |
| 2007 Q1 | 925.95 Thousand CAD | -3.97% |
| 2007 Q2 | 924.96 Thousand CAD | -0.11% |
| 2006 Q1 | 277.09 Thousand CAD | -26.45% |
| 2006 FY | 964.27 Thousand CAD | 155.93% |
| 2006 Q4 | 964.27 Thousand CAD | -3.58% |
| 2006 Q3 | 1 Million CAD | 9.14% |
| 2006 Q2 | 916.33 Thousand CAD | 230.69% |
| 2005 Q3 | 692.22 Thousand CAD | -35.3% |
| 2005 Q1 | 1.85 Million CAD | 161.16% |
| 2005 FY | 376.77 Thousand CAD | -47.08% |
| 2005 Q2 | 1.06 Million CAD | -42.45% |
| 2005 Q4 | 376.77 Thousand CAD | -45.57% |
| 2004 Q1 | 136.91 Thousand CAD | -45.42% |
| 2004 Q2 | 147.92 Thousand CAD | 8.04% |
| 2004 Q3 | 238.15 Thousand CAD | 61.0% |
| 2004 Q4 | 711.9 Thousand CAD | 198.92% |
| 2004 FY | 711.9 Thousand CAD | 183.79% |
| 2003 Q4 | 250.85 Thousand CAD | -40.3% |
| 2003 Q2 | 469.71 Thousand CAD | 37.8% |
| 2003 Q1 | 340.86 Thousand CAD | 0.0% |
| 2003 FY | 250.85 Thousand CAD | -27.68% |
| 2003 Q3 | 420.18 Thousand CAD | -10.54% |
| 2002 FY | 346.87 Thousand CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Achiko AG | 1.91 Million USD | 65.327% |
| Accelera Innovations, Inc | - USD | -Infinity% |
| Aspyra Inc. | 15.16 Million USD | 95.623% |
| Cannabis Sativa, Inc. | 2.02 Million USD | 67.148% |
| CompuMed, Inc. | 4.43 Million USD | 85.04% |
| CompuGroup Medical SE & Co. KGaA | 2.19 Billion USD | 99.97% |
| Cogstate Limited | 57.83 Million USD | 98.852% |
| CareView Communications, Inc. | 4.26 Million USD | 84.426% |
| Craneware plc | 543.65 Million USD | 99.878% |
| Caduceus Software Systems Corp. | 11.9 Million USD | 94.423% |
| Certive Solutions Inc. | 477.94 Thousand USD | -38.883% |
| Drug Free Solution, Inc. | 52.5 Thousand USD | -1164.188% |
| DATATRAK International, Inc. | 4.32 Million USD | 84.641% |
| Strainsforpains, Inc. | 1.57 Million USD | 57.761% |
| Healixa Inc. | 624.97 Thousand USD | -6.211% |
| Easy Technologies Inc. | - USD | -Infinity% |
| eWellness Healthcare Corporation | - USD | -Infinity% |
| Founders Bay Holdings | 25.52 Million USD | 97.399% |
| Health Discovery Corporation | - USD | -Infinity% |
| Healthcare Integrated Technologies, Inc. | 729.32 Thousand USD | 8.986% |
| H-Source Holdings Ltd. | - USD | -Infinity% |
| InterCare DX, Inc. | 0.07 USD | -948267042.857% |
| iCoreConnect Inc. | 15.68 Million USD | 95.768% |
| IQ-AI Limited | 917.49 Thousand USD | 27.652% |
| Cannabiz Mobile, Inc. | 137.8 Thousand USD | -381.675% |
| Mednow Inc. | 14.16 Million USD | 95.313% |
| Galileo Life Sciences, Inc. | 58.41 Thousand USD | -1036.31% |
| MediXall Group, Inc. | 862.01 Thousand USD | 22.996% |
| Mitesco, Inc. | 2838.00 USD | -23289.253% |
| MobileSmith, Inc. | 1.04 Million USD | 36.716% |
| NantHealth, Inc. | 159.55 Million USD | 99.584% |
| Net Medical Xpress Solutions, Inc. | 893 Thousand USD | 25.668% |
| OneLife Technologies Corp. | - USD | -Infinity% |
| ORHub, Inc. | 1.88 Million USD | 64.804% |
| Patient Access Solutions, Inc. | 489.19 Thousand USD | -35.69% |
| Pharma-Bio Serv, Inc. | 19.9 Million USD | 96.665% |
| PPJ Healthcare Enterprises, Inc. | 19.01 Million USD | 96.509% |
| Medical Cannabis Payment Solutions, Inc. | 38.23 Thousand USD | -1635.935% |
| Renalytix Plc | 7.97 Million USD | 91.674% |
| Revium Recovery Inc. | 5.63 Million USD | 88.21% |
| RYAH Group, Inc. | - USD | -Infinity% |
| Carepay Inc. | 3.81 Million USD | 82.618% |
| Vaso Corporation | 75.75 Million USD | 99.124% |
| Vynleads, Inc. | 36.4 Thousand USD | -1723.34% |